AxoGen (AXGN) Tops Q2 EPS by 9c

AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.03), $0.09 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $38.2 million versus the consensus estimate of $39.08 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group